To date, ETV6::ABL1 has been reported on various hematological malignancies, including B/T-acute lymphoblastic leukemia, acute myeloid leukemia (AML), and myeloproliferative neoplasm (MPN) [3, 4]. Here, ABL1 is linked to myeloproliferative neoplasm.